Year: 2018

Medical Technology Enterprise Consortium – Development of Personalized Bacteriophage Therapeutic for the treatment of Complicated and Multidrug Resistant Bacterial Infections (Pre-Announcement)

12/21/2018

UVA is a member of MTEC.  This is a members-only offering.  If you wish to speak with The Conafay Group, please contact Dr. David Driscoll (dld5dt). The Medical Technology Enterprise…

Klarman Family Foundation – Eating Disorders Research Grants Program

12/17/2018

Our fundamental mission is to understand the biology underlying the psychiatric disease anorexia nervosa, with the goal of accelerating progress towards prevention and treatment. We are seeking proposals to conduct research that…

NIH/NCI – Physical Sciences-Oncology Network (PS-ON): Physical Sciences-Oncology Projects (PS-OP) (U01 Clinical Trial Optional)

12/17/2018

The purpose of this funding opportunity announcement (FOA) is to invite applications for Physical Science-Oncology Projects (PS-OP). The goal of the PS-OPs is to promote a ‘physical sciences perspective’ of…

NIH – Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)

12/17/2018

The overall goal of the NIH Research Career Development program is to help ensure that a diverse pool of highly trained scientists is available in appropriate scientific disciplines to address…

NIH – HEAL Initiative: Early Phase Pain Investigation Clinical Network (three FOAs)

12/17/2018

HEAL Initiative: Early Phase Pain Investigation Clinical Network – Clinical Coordinating Center (U24 Clinical Trial Not Allowed (RFA-NS-19-023) National Institute of Neurological Disorders and Stroke National Center for Complementary and…

NIH – HEAL Initiative: Optimization of Non-addictive Therapies [Small Molecules and Biologics] to Treat Pain – (U44 Clinical Trial Not Allowed)

12/17/2018

The purpose of this funding opportunity announcement (FOA) is to support preclinical optimization and development of safe, effective, and non-addictive small molecule and biologic therapeutics to treat pain. The goal…

NIH – HEAL Initiative: Clinical Devices to Treat Pain (UH3 Clinical Trial Optional)

12/17/2018

The purpose of this Funding Opportunity Announcement (FOA) is to encourage investigators to pursue translational activities and clinical trials to treat pain with innovative, targeted, and non-addictive diagnostic and/or therapeutic…

NIH – HEAL Initiative: Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional) (two FOAs)

12/17/2018

HEAL Initiative: Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional) (RFA-NS-19-016) National Institute of Neurological Disorders and Stroke National Center for Advancing Translational Sciences National Center for Complementary and…

NIH – Center without Walls for PET Ligand Development for Alzheimer’s disease related dementias (ADRDs) (U19 Clinical Trial Optional)

12/17/2018

In 2016, NINDS organized a conference on Alzheimer’s Disease Related Dementias (ADRDs) which focused on  frontotemporal degeneration (FTD), Lewy body dementias (LBD) (including dementia with Lewy bodies (DLB)), Parkinson disease dementia (PDD),…

NIH – HEAL Initiative: Effectiveness Trials to Optimize, Implement, Scale, and Sustain the Collaborative Care Model for Individuals with Opioid Use Disorders and Mental Health Conditions (U01 Clinical Trial Required)

12/17/2018

This funding opportunity announcement (FOA) is being offered as part of the NIH’s Helping to End Addiction Long-term (HEAL) initiative to speed scientific solutions to the national opioid public health…